Skip to main content

UBS Group AG

Position in MTNB — Matinas BioPharma Holdings, Inc.

CIK 1610520 ZURICH, V8

Position in MTNB

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$92
-$263 QoQ
Shares Held
184
-69.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MTNB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,806 across 561 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in MTNB

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $92 184
2025-12-31 $355 607
2025-09-30 $378 200
2025-06-30 $97 110
2025-03-31 $852 1,640
2024-12-31 $6,279 12,313
2024-09-30 $12,131 3,427
2024-03-31 $12,166 44,893
2023-06-30 $5,150 14,307
2022-12-31 $5,926 11,852
2021-09-30 $13,382 10,294
2021-06-30 $1,970 2,543
2021-03-31 $18,382 17,507
2020-12-31 $2,307 1,697
2020-09-30 $109,693 143,203
2020-06-30 $85,291 110,338
2020-03-31 $4,962 8,270